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Over the past years, several lines of evidence have pointed out the efficacy of ferulic
acid (FA) in counteracting oxidative stress elicited by β-amyloid or free radical initiators,
based on the ability of this natural antioxidant to up-regulate the heme oxygenase-1
(HO-1) and biliverdin reductase (BVR) system. However, scarce results can be found
in literature regarding the cytoprotective effects of FA in case of damage caused by
neurotoxicants. The aim of this work is to investigate the mechanisms through which
FA exerts neuroprotection in SH-SY5Y neuroblastoma cells exposed to the neurotoxin
trimethyltin (TMT). FA (1–10 μM for 6 h) dose-dependently increased both basal and
TMT (10 μM for 24 h)-induced HO-1 expression in SH-SY5Y cells by fostering the
nuclear translocation of the transcriptional activator Nrf2. In particular, the co-treatment
of FA (10 μM) with TMT was also responsible for the nuclear translocation of HO-1 in an
attempt to further increase cell stress response in SH-SY5Y cells. In addition to HO-1,
FA (1–10 μM for 6 h) dose-dependently increased the basal expression of BVR. The
antioxidant and neuroprotective features of FA, through the increase of HO activity, were
supported by the evidence that FA inhibited TMT (10 μM)-induced lipid peroxidation
(evaluated by detecting 4-hydroxy-nonenal) and DNA fragmentation in SH-SY5Y cells
and that this antioxidant effect was reversed by the HO inhibitor Zinc-protoporphyrin-IX
(5 μM). Among the by-products of the HO/BVR system, carbon monoxide (CORM-2,
50 nM) and bilirubin (BR, 50 nM) significantly inhibited TMT-induced superoxide anion
formation in SH-SY5Y cells. All together, these results corroborate the neuroprotective
effect of FA through the up-regulation of the HO-1/BVR system, via carbon monoxide
and BR formation, and provide the first evidence on the role of HO-1/Nrf2 axis in
FA-related enhancement of cell stress response in human neurons.
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INTRODUCTION
For over 40 years, since Tenhunen et al. (1969) demonstrated
the heme-metabolizing activity of heme oxygenase (HO) with
the formation of biliverdin (BV) and carbon monoxide (CO),
and Mahin Maines – along with her group – documented the
regulation and distribution of major isoforms of the protein,
termed HO-1, and HO-2 (Cruse and Maines, 1988; Ewing
and Maines, 1991, 1992; Maines, 1997), numerous studies have
appeared in the literature showing the role of this enzyme in
the modulation of biological functions, including the complex
cellular response to stress in many cells and tissues (Mancuso
et al., 2007; Motterlini and Foresti, 2014; Wegiel et al., 2014).
Over the years, biliverdin reductase (BVR), the other enzyme
that is functionally linked with HO, has been extensively studied
leading to important discoveries, such as the ability to reduce
BV into bilirubin (BR) using diﬀerent cofactors depending on
the intracellular pH (Kutty and Maines, 1981). Although the
two isoforms of HO catalyze the same reaction, HO-1 is mainly
involved in the adaptive response to cellular oxidative and
nitrosative stress caused by an increased production of reactive
oxygen and nitrogen species (ROS and RNS, respectively; Bach,
2005; Gozzelino et al., 2010), whereas HO-2 is primarily involved
in the physiological regulation of heme metabolism (Maines,
1997; Maines and Panahian, 2001). Regarding BVR, in addition
to the above mentioned reductase activity, recent studies have
also shown the kinase activity on serine, threonine, and tyrosine
residues which makes this protein unique in regulating the
intracellular redox state and metabolism (Lerner-Marmarosh
et al., 2005, 2007). A biological role for the HO/BVR system has
been demonstrated in the central nervous system (CNS) where
CO was involved in the processes of long-term potentiation
(Verma et al., 1993; Zhuo et al., 1993) and neuropeptide release
(Mancuso et al., 1997, 1999; Errico et al., 2010), whereas a strong
antioxidant activity, through the interaction with ROS/RNS
(Stocker et al., 1987; Barone et al., 2009b; Mancuso et al.,
2012), and neurotrophic features (Mancuso et al., 2008) were
documented for BR. On these grounds, numerous researchers
have put forth the hypothesis regarding the usefulness of HO-
1 and BVR up-regulation, particularly in the case of diseases
caused by an excessive production of free radicals, such as
neurodegenerative disorders. A common approach is the use of
natural products, such as (poly)phenols, particularly abundant in
fruits and vegetables, which have proved capable of increasing
the expression of HO-1 in preclinical in vitro and in vivo systems
(Scapagnini et al., 2011).
Among the phenolic acid derivatives, one of the most studied
for its neuroprotective activity was ferulic acid (FA), particularly
abundant in vegetables (aubergines, tomatoes, artichokes), fruits,
grains, and some beverages (Mancuso and Santangelo, 2014).
FA counteracted the oxidative/nitrosative stress due to the
amyloid-β-peptide (Aβ) or other radical initiators, such as
AAPH and iron/hydrogen peroxide, in neural cells with multiple
mechanisms, including the activation of cell stress response
(Kanski et al., 2002; Joshi et al., 2006; Perluigi et al., 2006;
Picone et al., 2009). FA was also shown to potentiate the
cell stress response in an in vivo model of neurodegeneration,
namely the middle cerebral artery occlusion in rats, through
the activation of both peroxiredoxin-2 and thioredoxin (Sung
et al., 2014). In addition to these antioxidant eﬀects, FA was
demonstrated to contribute to the maintenance of homeostasis
by modulating cellular autophagy, which is a well-known
mechanism involved in the processing and elimination of
misfolded proteins (Bian et al., 2013). These ﬁndings have
led many researchers to hypothesize an adjuvant role for
FA in neurodegenerative diseases characterized by cognitive
impairment, such as Alzheimer’s disease. However, scarce
evidence is present in literature concerning the neuroprotective
action of FA in the event of damage due to neurotoxins,
such as the trimethyltin (TMT), that causes brain damage with
multiple mechanisms including the production of ROS and RNS
(Gunasekar et al., 2001; Qu et al., 2011). These considerations
prompted us to study the possible neuroprotective role of FA
in human neuroblastoma cells, SH-SY5Y, exposed to TMT;
furthermore, the research has assessed whether FA is able to
enhance the HO-1/BVR system, thus reducing the neurotoxic
eﬀects of TMT in the SH-SY5Y cells.
MATERIALS AND METHODS
Chemicals
All chemicals were purchased from Sigma–Aldrich (Milan, Italy)
unless otherwise speciﬁed. FA, BR, and Zinc-protoporphyrin-
IX (ZnPP or ZnPP-IX, Frontier Scientiﬁc, Logan, UT, USA)
were dissolved in alkaline aqueous solution, whereas TMT in
deionized water. Tricarbonyldichlororuthenium (II) (CORM-2)
was dissolved in DMSO at the stock solution of 10 mM.
Cell Culture
SH-SY5Y neuroblastoma cells were provided through
the courtesy of Prof. Randall N. Pittman (Department of
Pharmacology, University of Pennsylvania, Philadelphia, USA)
and cultured in Minimum Eagle’s Medium (MEM, Euroclone,
Pero, Italy):F12 (Gibco, Life Tecnologies, Monza, Italy)
supplemented with 1X non-essential aminoacids (Euroclone),
1 mM sodium pyruvate (Gibco), 1.5 g/L sodium bicarbonate, 1%
penicillin/streptomycin (Euroclone) and 10% fetal calf serum
(FCS, Euroclone).
The day before the experiment, 1.2× 106 SH-SY5Y cells (10th–
14th passage) were seeded in six-multiwell plates at a density of
120,000 cells/cm2. After overnight incubation, cells were treated
with FA (1–10 μM) for 6 h in 1% FCS medium. At the end of
incubation, the medium was removed and replaced with 1% FCS
medium containing TMT (10 μM) for further 24 h. In selected
dose-response experiments, SH-SY5Y cells were treated either
with FA (1–10 μM) for 6 h and then 24 h with plain medium
or with TMT (1–10 μM) for 24 h.
Western Blot
SH-SY5Y cells, treated as described above, were lysed in RIPA
buﬀer (Sigma–Aldrich, Milan, Italy) for 15 min in ice. After
centrifugation (12,000 rpm, 15 min, 4◦C), supernatant aliquots
were used to determine protein concentration using the DC
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protein assay kit (BIO-RAD, Segrate, Milan, Italy). Another
supernatant aliquot was boiled for 3 min after the addition of 1/6
reducing loading buﬀer 6X. A 30μg dose of protein was separated
by SDS-polyacrylamide gel electrophoresis (SDS-PAGE) on 12%
gel. Precision Plus ProteinTM Standards electrophoresis markers
(BIO-RAD) were used as molecular mass standards. Proteins
were then transferred onto nitrocellulose membranes by using
the Trans-Blot R©TurboTM Blotting System (BIO-RAD), according
to the manufacturer’s instructions, and stained with Ponceau
S (ICN Biochemicals, OH). Non-speciﬁc binding sites were
blocked with 5% dry milk in Tris-buﬀered saline (TBS) and
membranes were incubated overnight at 4◦C with the primary
rabbit anti-HO-1 (1:1000; Stressgen, Enzo Life Sciences, DBA
Italia, Segrate, Milan, Italy) and anti-BVR (1:1000; Stressgen)
antibodies. Membranes were then incubated with a horseradish
peroxidase conjugated anti-rabbit (1:3000, BIO-RAD) IgG
secondary antibody and then developed using the enhanced
chemiluminescence reagents ClarityTM Western ECL substrate
(BIO-RAD). The bands were visualized by autoradiography
using UltraCruzTM autoradiography ﬁlms (DBA Italia). An anti-
β-actin rabbit monoclonal antibody (1:1000; Stressgen) was used
to detect β-actin to conﬁrm equal protein loading; in selected
experiments, nitrocellulose membranes were stripped and then
re-probed with the anti-β-actin antibody. The obtained ﬁlms
were evaluated for densitometry bymeans of an optical computed
system (GEL-DOCTM EM Imager, BIO-RAD). The HO-1 or
BVR/β-actin ratio was calculated and expressed as a percentage
compared to the control group.
Immunofluorescence Analysis
In order to perform immunoﬂuorescence for 4-HNE, Nrf2, and
HO-1, 300,000 cells, seeded in glass coverslips (10 mm diameter)
were treated as previously described. In selected experiments to
evaluate 4-HNE and DNA fragmentation, cells were incubated
with ZnPP (5 μM) in the presence of FA (10 μM for 6 h)
and TMT (10 μM for further 24 h). Cells were ﬁxed with 4%
paraformaldehyde for 15 min at room temperature, permeated
with 0.1% Triton-X for 15 min before being blocked in 0.3%
BSA for 20 min. Samples were then incubated for 3 h with
primary rabbit anti-4-HNE (Cat#HNE11-S, Alpha Diagnostic
Int., San Antonio, TX, USA) or mouse anti-Nrf2 (Abcam,
Cambridge, UK) and rabbit anti-HO-1 (Stressgen, Ann Arbor,
MI, USA) antibodies diluted 1:100 in 0.3% BSA in PBS. At
the end of incubation, all samples were washed twice in PBS
and incubated at room temperature for 90 min, light-protected,
with secondary antibodies diluted 1:1000 in PBS. Goat anti-
rabbit 488 (Alexa Fluor) was used for 4-HNE and HO-1,
whereas donkey anti-mouse 546 (Alexa Fluor) was used to
detect Nrf2 labeling. Moreover, cell nuclei were counterstained
with DAPI (1:1000 in PBS) for 10 min at room temperature,
in a light-protected environment. Subsequently, the samples
were coverslipped with an antifade medium (ProLong Gold;
Invitrogen). Images (20×) were obtained with a confocal laser
scanning system (TCSSP2, Leica) equipped with an Ar/ArKr
laser (for 488 nm excitation) and HeNe laser (for 543 nm
excitation). DAPI staining was imaged by two photon excitations
(740 nm, <140 fs, 90 MHz) performed with an ultrafast, tunable
FIGURE 1 | Trimethyltin (TMT) increases both heme oxygenase-1
(HO-1) and biliverdin reductase (BVR) expression in SH-SY5Y cells.
SH-SY5Y cells were treated with TMT (1–10 μM) for 24 h and Western Blot
was performed as described in the section “Materials and Methods.” (A)
shows representative gels regarding HO-1 and BVR protein expression. Bar
graphs represent the quantification of HO-1 (B) and BVR (C) protein levels
normalized for β-actin expression. Data are expressed as a mean ± SEM of
4–7 replicates per group. ∗∗P < 0.01 vs. controls. C, controls.
mode-locked Ti:sapphire laser (Chameleon; Coherent Inc., Santa
Clara, CA, USA).
Concerning Nrf2 and HO-1 immunoﬂuorescence,
20 μm-thick confocal Z-stacks in series were acquired as
images of 1024 pixels × 1024 pixels, reordered at intervals
of 0.5 μm, in order to evaluate the real extent of the
nuclear and/or cytosolic ﬂuorescence in high magniﬁcations
(63×).
The optical density analysis to quantify ﬂuorescence signal was
performed by using Leica Confocal Software (LCS Lite); each
evaluation was conducted on ﬁve ﬁelds randomly selected for
each of the experimental conditions.
DNA Fragmentation
DAPI staining was used to identify nuclear fragmentation
and condensed nuclei in SH-SY5Y cells. Brieﬂy, 300,000
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FIGURE 2 | Ferulic acid (FA) effects on TMT-induced heme oxygenase-1 (HO-1) and BVR expression in SH-SY5Y cells. SH-SY5Y cells were treated with
FA (1–10 μM) for 6 h and then incubated with TMT (10 μM) for further 24 h (A–C); in another group of experiments SH-SY5Y cells were treated with FA (1–10 μM)
for 6 h and, subsequently, incubated with plain medium for additional 24 h (D–F). Following incubation, cells were harvested and Western Blot was performed as
described in the section “Materials and Methods.” (A) and (D) show representative gels regarding HO-1 and BVR protein expression. Bar graphs represent the
quantification of HO-1 (B,E) and BVR (C,F) protein levels normalized for β-actin expression. Data are expressed as a mean ± SEM of eight replicates per group.
∗P < 0.05 and ∗∗P < 0.01 vs. controls, ◦P < 0.05 vs. TMT. C, controls.
cells/glass were ﬁxed with 4% paraformaldehyde for 15 min,
washed twice in PBS and then incubated in a DAPI containing
solution (1:1000 in PBS 0.1 M) and Triton (TX, 0.1% in PBS
0.1 M) for 10 min at room temperature and light-protected.
Samples were, then, washed in PBS and coverslipped with
an antifade medium (ProLong Gold; Invitrogen). Images
were taken at low (20×) and higher magniﬁcation (40×)
by a confocal laser scanning microscope (TCS-SP2; Leica
Microsystem, GmbH, Wezlar, Germany). To highlight
changes in morphology like nuclear condensation and
cellular fragmentation, DAPI staining was imaged by two-
photon excitation (740 nm, <140 fs, 90 MHz) performed
by an ultrafast tunable mode-locked titanium:sapphire
laser.
Superoxide Anion Production
The content of intracellular superoxide anion was determined
by laser scanning confocal microscope analysis with
superoxide-sensitive ﬂuorescent probe dihydroethidium
(DHE, Invitrogen Molecular Probes). Brieﬂy, 300,000
cells/glass in diﬀerent culture conditions (see Results)
were incubated with DHE (10 μM) at 37◦C for 30 min
in the dark. The cells were washed twice with PBS
and images were taken by a confocal laser scanning
microscope (TCS-SP2; Leica Microsystem, GmbH, Wezlar,
Germany) using two-photon excitation (792 nm, >140 fs,
90 MHz) performed by an ultrafast tunable mode-locked
titanium:sapphire laser (Chameleon; Coherent). The optical
density analysis was performed to quantify superoxide
anion ﬂuorescence signals by using LCSLite, Leica Confocal
Software.
Statistical Analyses
Results are presented as mean ± standard error of the
mean (SEM) of N replicates per group. Data sets have
been analyzed by One-way ANOVA corrected by the Dunnet
or Newman–Keul tests for comparison within the same
group or more groups, respectively (Prism 4.0 software,
GraphPad Software). Diﬀerences were considered signiﬁcant at
P < 0.05.
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FIGURE 3 | Ferulic acid induces Nrf2 activation and translocation into the nucleus. (A–D) Representative images from four independent
immunofluorescence experiments in which we performed a double-labeling with DAPI (A1–D1) and an anti-Nrf2 antibody (A2–D2). Merged images are shown in
(A3–D3). XZ and YZ cross-sections in the boxes (referred to the dashed lines) from the confocal Z-stack acquisitions illustrate cytosolic or nuclear fluorescence
signal(s) (XZ and YZ boxes: a1–d1 refer to DAPI staining; a2–d2: refer to Nrf2 fluorescence; a3–d3: Merge). In cells treated with TMT, a strong Nrf2 activation was
detected which, however, remains mainly confined in the cytoplasm (b1–b3 in B). In TMT + FA treated cells, there was a further cytoplasmic enhancement of Nrf2
expression compared to TMT alone which also translocates into the nucleus as indicated by Z-stack acquisitions (c1–c3 in C). FA administration (10 μM) induced an
endogenous antioxidant response leading to a strong increase in Nrf2 expression in the cytosol (d1–d3 in D) compared to Control (a1-a3 in A). Scale bar: 20 μm. For
further information see text.
RESULTS
TMT Activates the HO-1/BVR System
Since only one work has been found in literature concerning the
eﬀect of TMT on HO-1, in a preliminary series of experiments,
it was necessary to study the eﬀect of TMT on the expression
of HO-1 and BVR in SH-SY5Y cells. The incubation time of
24 h of the cells with TMT was chosen since literature data have
shown that the production of ROS and the consequent oxidative
stress continue during the 24 h following the treatment of
primary cultures of rat cerebellar neurons with this neurotoxicant
(Gunasekar et al., 2001). As shown in Figure 1, TMT (1–
10 μM for 24 h) dose-dependently increased HO-1 and BVR
expression. However, only at the concentration of 10 μM, TMT
increased both HO-1 and BVR protein expression reaching
statistical signiﬁcance. In light of this, TMT was used at
the concentration of 10 μM for 24 h in the subsequent
experiments.
FA-Induced Modulation of HO-1/BVR in
TMT-Treated SY5Y Cells
As regards FA, Sultana et al. (2005) have shown its ability to
increase the expression of HO-1 as early as 1 h of incubation
in cortical neurons. However, time-course experiments carried
out speciﬁcally for this study, have shown it takes at least
6 h of incubation of SH-SY5Y cells with FA for a signiﬁcant
induction of HO-1 (data not shown) and, for this reason, in
subsequent experiments, cells were incubated with FA for 6 h,
also in accordance with previous studies (Scapagnini et al., 2004).
The range of FA doses, namely 1–10 μM, was decided taking
into consideration the magnitude of plasma concentration of
FA in humans and also according to previous studies that have
allowed the calculation of the EC50 of this antioxidant in reducing
the ROS/RNS damage in rat brain microsomes (Barone et al.,
2009a; Trombino et al., 2013; Mancuso and Santangelo, 2014). As
shown in Figures 2A–C, FA (1–10 μM) signiﬁcantly enhanced
TMT-induced HO-1 expression in SH-SY5Y cells, whereas the
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FIGURE 4 | Ferulic acid induces HO-1 expression and its nuclear translocation. (A–D) Representative images from four independent immunofluorescence
experiments in which we carried out a double-labeling with DAPI (A1–D1) and an anti-HO-1 antibody (A2–D2). Merged images are shown in A3–D3. XZ and YZ
cross-sections in the boxes (referred to the dashed lines) from the confocal Z-stack acquisitions show cytosolic or nuclear fluorescence signal(s) (XZ and YZ boxes:
a1–d1 refer to DAPI staining; a2–d2 refer to HO-1 fluorescence; a3–d3: Merge). In the Control group (A) a faint HO-1 fluorescence localized in the cytosol was
detected (a1–a3). In TMT (10 μM) treated cells (B) HO-1 fluorescence was strong and primarily localized in the cytoplasm (b1–b3). In TMT (10 μM) + FA (10 μM)
samples (C) a marked HO-1 activation both in cytoplasm and nucleus was observed, as indicated by Z-stack acquisitions (c1–c3). FA (10 μM) treatment induced a
strong or moderate increase of HO-1 labeling, localized in the cytoplasm and nucleus, respectively (d1–d3 in D). Scale bar: 20 μm. For further information see text.
TABLE 1 | Nrf2 and HO-1 fluorescence signals (average optical density
values from four independent experiments) in the cytosol and nucleus of
SH-SY5Y cells.
Nrf2 HO-1
Cytosol Nucleus C/N Cytosol Nucleus C/N
Control 18.5 9.33 1.98 11.1 6.67 1.66
TMT 10 μM 72.4 42.4 1.70 36.4 13.5 2.69
TMT 10 μM+
FA 10 μM
97.7 83.3 1.17 95.7 87.0 1.10
FA 10 μM 69.0 74.7 0.92 62.4 17 3.67
C/N, cytosol/nucleus ratio.
antioxidant did not have any relevant eﬀect on TMT-induced
BVR expression. Interestingly, FA (1–10 μM) also increased, in
a dose-dependent manner, basal HO-1 and BVR expression in
SY5Y cells (Figures 2D–F).
Since one of the main mechanisms by which HO-1 is
expressed is the translocation of the transcription factor Nrf2,
from the cytoplasm to the nucleus, where it binds the antioxidant
responsive element (ARE) region of the gene promoter HO-1,
one of the goals of the study was to investigate whether the
increased expression of HO-1, induced by FA, had depended on
the nuclear translocation of Nrf2 in SH-SY5Y cells. Figures 3 and
4 shows representative Nrf2 (red ﬂuorescence) and HO-1 (green
ﬂuorescence) immunostainings of SY5Y cells treated with TMT
(10 μM) and FA (10 μM), i.e., the most eﬀective concentrations
that modulate HO-1. The intensity of ﬂuorescence signal for
Nrf2 and HO-1 was quantiﬁed by measuring the optical density
in the cytosol and nucleus of SH-SY5Y and, afterwards, the
cytosol/nucleus ratio (C/N) was calculated. In control samples,
Nrf2 was mainly displaced in the cytosol (Figure 3A) and a faint
HO-1 expression was observed in this compartment (Figure 4A,
Table 1) as shown by the XZ and YZ cross-sections from
the Z-stack acquisitions (boxes a1–a3 in Figures 3A and 4A,
respectively). Amoderate-to-strong increase in Nrf2 ﬂuorescence
(Figure 3B, Table 1) was detected in TMT-treated cells, mainly
located inside the cytosol, although Z-stack and optical density
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FIGURE 5 | Ferulic acid counteracts the increase of lipid peroxidation induced by TMT in a dose-dependent manner. (A–H) Representative
immunofluorescence images of SH-SY5Y cells treated with TMT (10 μM) and/or FA (1–10 μM) and double stained with DAPI (blue) and anti-4-HNE antibody (green).
4-HNE labeling was faint in control cells (A), but mildly increased in cells treated with different doses of FA (B–D). After TMT treatment, there was a marked increase
of 4-HNE fluorescence (E) that decreased in a dose-dependent manner when FA was added (F–H). (I) Histograms (mean ± SEM) showing optical density
quantification in treated cells for 4-HNE labeling. Data are representative of three independent experiments; each count was performed on five fields randomly
selected for each experimental condition. Scale bar (A–H) 20 μm. ∗P < 0.05, ∗∗P < 0.01 vs. controls (C), ◦◦P < 0.01 vs. TMT.
analysis showed a comparable nuclear accumulation of the
transcription factor (boxes b1–b3) in SY5Y cells. Simultaneously,
a similar enhancement in HO-1 (Figure 4B, Table 1) expression
conﬁned inside the cytosol (boxes b1–b3) was observed in the
same samples. The combined treatment with TMT and FA
further increased Nrf2 expression (Figure 3C, Table 1) with
respect to TMT alone. As clearly indicated by XZ and YZ cross-
sections, the Nrf2 ﬂuorescence signal was further increased,
not only in the cytosol, but also in the nucleus, in SY5Y cells
exposed to TMT + FA (boxes c1–c3 in Figure 3C, Table 1).
Interestingly, SY5Y cells treated with TMT + FA showed also
a marked over-expression of HO-1 (Figure 4C, Table 1), both
in the cytosol and in the nucleus (boxes c1–c3, XZ and YZ
cross-sections). The administration of FA (10 μM) induced a
strong activation of Nrf2, which translocated into the nucleus, as
shown by the XZ and YZ cross-sections (boxes d1–d3 Figure 3D,
Table 1). Moreover, a remarkable increase of HO-1 labeling
was observed, primarily inside the cytosol whereas a moderate
immunostaining was also detected in the nucleus (boxes d1–
d3 Figure 4D, Table 1). The data in Table 1 allow to conclude
that the enhancement of Nrf2 expression and its translocation
into the nucleus parallels the up-regulation of HO-1 protein
expression under all the experimental conditions; however, FA
and TMT mainly increased the cytosolic HO-1 (C/N 3.67
and 2.69, respectively) whereas FA + TMT increased HO-1
immunostaining in the cytosol but much larger into the nucleus
(C/N 1.10).
FA-Regulated Lipid Peroxidation and
DNA Fragmentation in TMT-Treated
SY5Y Cells
Among the most common ways by which free radicals
irreversibly damage cells are lipid peroxidation and DNA
damage. 4-hydroxy-nonenals (4-HNE) are widely used as
biomarkers of lipid peroxidation also because they are considered
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FIGURE 6 | Ferulic acid neutralizes TMT-induced DNA fragmentation through the modulation of HO activity. Representative immunofluorescence images
of SH-SY5Y cells stained with DAPI at low magnification (20×, A–D) and high magnification (40×, a1–d2). Control cells (A) showed no morphological signs of DNA
fragmentation. TMT (10 μM, B) induced morphological signs of cytotoxicity such as nuclei condensation and nuclear fragmentation (see arrows). This effect was
counteracted by FA (10 μM, C) pre-treatment. When HO activity was inhibited by ZnPP (5 μM) in TMT (10 μM) + FA (10 μM) treated cells (D), nuclear fragmentation
and condensed nuclei were detected, with no difference compared to TMT treatment (see arrows). Scale bar: (A–D) 20 μm; a1–d2: 5 μm. For further information
see text.
very cytotoxic products (Subramaniam et al., 1997). As far
as DNA damage, free radicals are responsible for single- or
double-strand breaks, tandem lesions and other types of adducts
which, ultimately, lead to DNA fragmentation (Dizdaroglu
and Jaruga, 2012). As shown in Figure 5, TMT (10 μM
for 24 h) markedly increased 4-HNE levels in SH-SY5Y
cells; when the latter were pre-treated with FA (1–10 μM
for 6 h), TMT-induced 4-HNE formation was reduced in
a dose dependent manner, reaching signiﬁcant values at a
concentration of FA 5 μM and further decreasing to 10 μM.
Interestingly, FA (1–10 μM) mildly increased basal 4-HNE
formation, reaching statistical signiﬁcance at 1 μM. With
regard to DNA damage, TMT (10 μM for 24 h) clearly
increased DNA fragmentation in SH-SY5Y cells (Figure 6B)
and this eﬀect was counteracted by FA (10 μM for 6 h;
Figure 6C).
SH-SY5Y cells were treated with ZnPP – a well known
inhibitor of HO activity – in order to conﬁrm that FA
counteracted TMT-induced 4-HNE formation and DNA
fragmentation by modulating HO activity. At the concentration
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FIGURE 7 | Ferulic acid inhibits lipid peroxidation through the HO activity. (A–D) Representative immunofluorescence images of SH-SY5Y cells treated with
TMT (10 μM), FA (10 μM), and ZnPP-IX (5 μM) double stained with DAPI (blue) and an anti-4-HNE antibody (green). 4-HNE labeling was faint in control cells (A).
After TMT treatment, a remarkable increase of 4-HNE fluorescence was detected (B). The combined treatment with TMT and FA decreases significantly lipid
peroxidation (C) whereas, when cells were treated with TMT and FA and ZnPP, 4-HNE labeling remains marked similarly to the result observed in TMT treated cells
(D). (E) Bar graphs (mean ± SEM) showing optical density quantification in treated cells for 4-HNE labeling. Data are representative of three independent
experiments; each count was performed on five fields randomly selected for each experimental condition. Scale bar (A–D) 20 μm. For further information see text.
∗∗P < 0.01 vs. controls (C), ◦◦P < 0.01 vs. TMT.
of 5 μM, ZnPP has antagonized both the reduction of the
4-HNE levels (Figure 7) and DNA fragmentation (Figure 6D)
caused by 10 μM FA, thus conﬁrming the hypothesis that
the antioxidant action of FA is connected to the HO activity.
It is worth emphasizing that the concentration of ZnPP,
used is well below the concentration limit at which it
remains selective concerning HO without any eﬀect on
other heme proteins, such as NOS and sGC (Appleton et al.,
1999).
With the aim to evaluate which by-product of the HO/BVR
activities was involved in the FA’s antioxidant features, the
eﬀects of both CORM-2 (a CO donor) and BR against TMT-
induced superoxide anion production were tested in SH-SY5Y
cells. The major concern we had to face with, while designing
these experiments, was the choice of both BR and CORM-2
concentrations so that they could not result toxic when co-
administered with TMT. In order to overcome this issue, we
decided to use BR (50 nM), a concentration found safe for
SH-SY5Y cells by Dal-Cim et al. (2012); CORM-2 was used
at the same concentration of BR for proper comparison. In
this experimental setting SH-SY5Y cells were incubated with
either BR (50 nM) or CORM-2 (50 nM) for 6 h and then
the culture medium replaced with fresh medium containing
TMT (10 μM) plus BR or CORM-2, as above, for further
24 h. In an attempt to maintain a continuous release of CO,
CORM-2-containing cell culture media were replaced every 6 h.
As shown in Figure 8, CORM-2 (50 nM) and BR (50 nM)
signiﬁcantly reduced TMT (10 μM)-induced superoxide anion
generation in SH-SY5Y cells. Neither BR nor CORM-2 had any
signiﬁcant eﬀect on basal superoxide anion production (data not
shown).
DISCUSSION
Very little evidence has proven the eﬀects of FA in the
event of brain damage due to the action of neurotropic
xenobiotics, such as the neurotoxin TMT, despite the large
number of studies showing the protective eﬃcacy of FA in
synaptosomes or neural cells exposed to free radical generators,
including Aβ (Kanski et al., 2002; Joshi et al., 2006; Perluigi
et al., 2006). Only one study is present in the literature on
this topic and it identiﬁes the modulation of choline acetyl-
transferase as eﬀector of the long-term neuroprotective activity
of FA on TMT-induced cognitive impairment in mice (Kim
et al., 2007). However, in their paper, Kim et al. (2007) did
not evaluate the role of FA on TMT-induced free radical
generation and redox imbalance which are considered important
mechanisms in the pathogenesis of TMT damage in neural
cells (Corvino et al., 2013). Bearing this in mind, we decided
to open this new route and study the eﬀect of FA on TMT-
induced oxidative damage in SH-SY5Y, a human neuronal
cell line widely used for research on the mechanisms of
neurodegeneration/neuroprotection (Li et al., 1996; Bhat et al.,
2000; Uberti et al., 2002). Furthermore, we also investigated the
neuroprotective eﬀectiveness of the HO-1/BVR system -which
plays a prominent role in the cellular stress response- on TMT
neurotoxicity.
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FIGURE 8 | TMT-induced superoxide production. (A–D) Representative
immunofluorescence images of SH-SY5Y cells treated with TMT (10 μM),
CORM-2 (50 nM) and bilirubin (BR, 50 nM) and stained with DHE. In control
cells, DHE staining was faint (A). TMT (10 μM) induces a great increase in
superoxide production, as indicated by the rise of red fluorescence (B). When
cells are treated with TMT (10 μM) + CORM-2 (50 nM; C) or TMT
(10 μm) + BR (50 nM; D), ROS production significantly decreases with
respect to TMT alone. In (E), a bar graph (mean ± SEM) showing
fluorescence signal quantification in treated cells for 4-HNE labeling. Data are
representative of three independent experiments performed on five field
selected randomly. Scale bar: 20 μm. Magnification: 40×. For further
information see text. ∗∗P < 0.01 vs. controls (C), ◦◦P < 0.01 vs. TMT.
One of the ﬁrst results to be discussed is that, when the SH-
SY5Y cells were treated with FA (1–10 μM) in the presence of
TMT (10μM), the former has signiﬁcantly and dose-dependently
enhanced the activation of HO-1 by the latter (Figures 2A,B).
This ﬁnding shows that, under pro-oxidants conditions, such
as those generated by the administration of TMT (Figures 5
and 6), FA further increases the expression of HO-1, yielding
a particularly marked result at the concentration of 10 μM
FA. FA had no eﬀect on the expression of BVR induced by
TMT (Figures 2A,C). Interestingly, FA (1–10 μM) increased,
in a dose-dependent manner, the expression of HO-1 and BVR
also in SH-SY5Y cells not treated with TMT (Figures 2D–F),
conﬁrming its nature of hormetin (Barone et al., 2009a). Indeed,
1 μM FA had a type of pro-oxidant eﬀect on SH-SY5Y cells,
as demonstrated by the signiﬁcant increase of 4-HNE, and this
event may have triggered the initial overexpression of HO-1
(+18% vs controls; Figures 2D,E and 5). At doses of 5 μM
and 10 μM FA, the induction of HO-1 in SH-SY5Y cells further
increased (+42 and +84% vs. controls, respectively) and the
production of 4-HNE progressively decreased (Figures 2D,E
and 5). Therefore, the increased basal expression of HO-1, may
have start a particular antioxidant “prophylactic” action by FA
in a subsequent attack due to an excessive production of free
radicals.
The mechanism by which FA induced HO-1, both in
basal conditions and in the presence of TMT, is linked to
the activation of Nrf2 and its translocation from cytosol to
the nucleus (Figure 3). This evidence is somewhat new in
neural cells, as the eﬀects of FA on the Nrf2/HO-1 axis
have been studied only in lymphocytes and endothelial cells
(Ma et al., 2010, 2011). A qualifying part of our study is
that it also highlights the translocation of HO-1 from the
cytosol to the nucleus in SH-SY5Y cells exposed to FA alone
or in combination with TMT (Figures 3 and 4). Previous
studies have shown the nuclear translocation of HO-1 in
human prostate cancer cells, murine ﬁbroblasts and mouse
hepatoma cells exposed to strong oxidant conditions, such
as cigarette smoke or hypoxia or hemin with or without
hemopexin (Lin et al., 2007; Sacca et al., 2007; Birrane
et al., 2013). In all these studies, the presence of HO-
1 in the nucleus, due to strong pro-oxidant stimuli, was
considered a functional mechanism which could enhance the
transcription of other cytoprotective genes able to counteract
oxidative damage. In the present study, FA-induced HO-
1 overexpression seems to be related mainly to the Nrf2
translocation from the cytosol to the nucleus, whereas when
the antioxidant was co-administered with TMT not only
increases Nrf2-stimulated cytosolic HO-1, but this condition
favors HO-1 nuclear translocation, arguably with the purpose
to enhance the antioxidant response. The question if and
which other neuroprotective genes may have been induced
by FA through the nuclear translocation of HO-1 and their
possible eﬀect is outside the scope of this work, which,
however, has fully addressed the antioxidant eﬀectiveness of
FA through the enzymatic activity of HO. Indeed, FA (1–
10 μM) signiﬁcantly reduced, in a dose-dependent fashion,
TMT-induced 4-HNE generation and DNA fragmentation in
SH-SY5Y cells and this eﬀect was counteracted by the HO
inhibitor ZnPP (Figures 5–7). Evidence -suggesting that the
ZnPP has abolished the antioxidant eﬀects of FA bringing the
production of 4-HNE and DNA damage to levels corresponding
to those caused by the administration of TMT- indicates that,
in our experimental system, the antioxidant activity of FA is
almost completely due to the activation of HO-1 and its eﬀect
on free radicals. The result about a signiﬁcant antioxidant
activity for FA against TMT-induced neurotoxicity, together
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with the ﬁnding of amarked nuclear translocation of HO-1 under
this experimental condition (C/N 1.10), reinforce each other and
lend support to the hypothesis that HO-1 nuclear translocation is
critical for the neuroprotective activity of FA.
With regard to the “ultimate protectant” responsible for
the FA’s antioxidant eﬀect, both CORM-2 and BR, at low
concentrations, signiﬁcantly reduced TMT-induced superoxide
anion production in SH-SY5Y cells (Figure 8). That said, it is
noteworthy to recall also the importance of heme reduction as
an additional antioxidant mechanism.
CONCLUSION
Our studies have shown that FA plays neuroprotective eﬀects on
cell lines of human neurons through the activation of the HO-
1/Nrf2 system, probably via CO and BR production, and how it is
responsible for reducing the oxidizing eﬀects of the neurotoxin,
TMT.
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